Laurion Capital Management LP Jazz Pharmaceuticals PLC Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $708,766 - $811,324	6,819 New	6,819 $727,000
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $5.23 Million - $7.52 Million	-40,688 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$160.2 - $186.42 $5.62 Million - $6.54 Million	35,088 Added 626.57%	40,688 $7.23 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $4.39 Million - $5.07 Million	-29,223 Reduced 83.92%	5,600 $920,000
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $4.9 Million - $5.75 Million	34,823 New	34,823 $5.75 Million

511

57.8M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.